Nitrofurantoin Pulmonary Toxicity: A Brief Review

Authors: Vahid, Bobbak¹; Wildemore, Bernadette M.M.¹

Source: Current Respiratory Medicine Reviews, Volume 2, Number 4, November 2006 , pp. 439-442(4)

Publisher: Bentham Science Publishers

Key:

- Free Content

- New Content

- Subscribed Content

- Free Trial Content

Abstract:

Nitrofurantoin is an antimicrobial agent that is commonly used for the treatment of recurrent urinary tract infection. Nitrofurantoin pulmonary toxicity can present as acute, subacute, or chronic respiratory disease. Common manifestations are dry cough, chest pain, dyspnea, and hypoxemia. Skin rash, arthralgia, and abnormal transaminases are occasionally present. Chest imaging shows patchy infiltrates and fibrosis. Treatment includes discontinuing the medication. Although the role of corticosteroids has not been well described, patients with respiratory symptoms or hypoxemia may benefit from a trial of corticosteroid therapy.

Keywords: Nitrofurantoin; drug-induced lung toxicity; organizing pneumonia; pneumonitis

Document Type: Research article

DOI: 10.2174/157339806778777276

Affiliations: 1: Thomas Jefferson University, Department of Pulmonary and Critical Care Medicine, 834 Walnut Street,Philadelphia, PA 19107, USA.

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$55.07 plus tax Refund Policy